Interventional Cardiology Market is Suspected to Gain a Perfect CAGR of 7.25% During Forecast 2019-2025
Market Highlights:
The Interventional
Cardiology Market is driven by several factors, such as technological
advancements in interventional cardiac devices, rising prevalence of cardiac
diseases, increasing preference for minimally invasive procedures, and
increasing geriatric population. For instance, approximate 500,000 patients
around the world undergo percutaneous coronary intervention each year for
stable angina, and the procedure is considered to provide substantial relief
from pain symptoms to patients.
Many market players are dominating the global interventional
cardiology market. The prominent players are involved in strategic agreements, product
launches, and joint ventures to brace their market positions. For instance, in
May 2018, Terumo Europe NV announced the launch of Ultimaster Tansei drug-eluting
stent in Europe.
Key Players
Some of the key players in the
global interventional
cardiology market are ABIOMED
(US), Abbott (US), ACIST Medical Systems, Inc. (the US), B. Braun Melsungen AG
(Germany), BD (US), Biosense Webster, Inc (US), Biotronik SE & Co. KG
(Germany), Boston Scientific Corporation (US), Cardinal Health (US), Cook
Medical (US), Edwards Lifesciences Corporation (US), GE Healthcare (US), Koninklijke
Philips N.V. (Netherlands), Life Vascular Devices Biotech S.L. (Spain), Medtronic (Ireland),
Merit Medical Systems, Inc (US), Terumo Corporation (Japan), and W. L. Gore
& Associates, Inc. (US).
Segmentation
·
The global interventional cardiology market has been segmented
based on type, and end user.
·
The market, based on type, has been segmented into stents, percutaneous
transluminal coronary angioplasty (PTCA) catheters, plaque modification
devices, coronary guidewires, and accessories. The market, based on stents, has
been further divided into drug-eluting stents, bare-metal stents, and bioresorbable
vascular scaffolds. The stents segment held a major share in 2018 owing to the increased
number of product launches by key players in the current years.
·
The global
interventional cardiology market has been segmented, based on end user, into hospitals,
cardiac catheterization laboratories, ambulatory surgical centers, and others. In
2018, the hospitals segment held the majority share of the market owing to the increasing
number of patient admissions due to coronary diseases
Regional Analysis
The market has been divided, by region, into the Americas, Europe,
Asia-Pacific, and the Middle East & Africa. The Americas held maximum share
in the base year 2018, owing to the high incidence rates of cardiac disorders
and strategic activities by major players in countries such as the US. The interventional
cardiology market in the Americas has further been branched into North America
and Latin America, with the North American market divided into the US and
Canada. The European interventional cardiology market has been categorized as Western
Europe and Eastern Europe. The Western European market has further been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The European market for interventional cardiology is expected to hold a
substantial share owing to the increase in the number of cardiac disorder
cases. For instance, in 2016, there were 66,076 deaths due to coronary heart
diseases in the UK, which was the third-highest cause of death in that
particular year. The interventional cardiology market in Asia-Pacific has been
segmented into Japan, China, India, South Korea, Australia, and the rest of
Asia-Pacific. The interventional cardiology market in this region is
anticipated to be the fastest-growing during the forecast period due to the increasing
uptake and adoption rate of newer treatment options by patients as well as
medical professionals. The increasing patient pool and mortality rate due to
cardiac diseases in these countries also fuel the market growth. For instance,
in 2017, ischemic heart disease was the second-highest cause for death in
Japan. The interventional cardiology market in the Middle East & Africa has
been divided into the Middle East and Africa.
Related
Reports:
Comments
Post a Comment